A carregar...
Acquired resistance to BRAF inhibition in BRAF(V600E) mutant gliomas
Activating mutation of BRAF is a common finding in pediatric gliomas. As many as 14% of high grade and up to 66% of certain subtypes of low grade pediatric glioma have the BRAF(V600E) mutation. Small molecule inhibitors that selectively target BRAF(V600E) are FDA approved for melanoma and have shown...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5352180/ https://ncbi.nlm.nih.gov/pubmed/27611946 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11882 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|